Florida, January 17, 2018 : The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine with the reasons given for variations in the growth of the industry in certain regions.

    The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and global Good Manufacturing Practice guidelines. One of the major restraint is that most of the hospital still rely on conventional diagnostic procedures and not able to shift to nuclear medicine due to cost and availability issues. The life of radiopharmaceuticals is small so that sometimes the use of this is restricted.

    The nuclear medicine market is expected to exceed more than US$ 4.5 billion by 2021 growing at around 9.0% CAGR for the given forecast period.

    Browser Full Report @:  https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market

    This report provides: 

    1) An overview of the global market for nuclear medicine and related technologies.

    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.

    3) Identifications of new market opportunities and targeted promotional plans for nuclear medicine.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    The Nuclear Medicine Market has been segmented as below: 

    By Procedural Volume Segment Analysis

    Diagnostics

    SPECT Radiopharmaceuticals

    PET Radiopharmaceuticals

    Therapeutics

    Beta Emitters

    Alpha Emitters

    Brachytherapy Isotopes

    By Type Analysis

    Diagnostics

    SPECT Radiopharmaceuticals

    Tc-99

    Tl-201

    Ga-67

    I-123

    PET Radiopharmaceuticals

    F-18

    Ru-82

    Others

    Therapeutics

    Beta Emitters

    I-131

    Sm-153

    Rh-186

    Y-90

    Lu-177

    Others

    Alpha Emitters

    Ra-223

    Brachytherapy Isotopes

    I-125

    Ir-192

    Pa-103

    Cs-131

    Others

    By Application Analysis

    • Diagnostics
    • SPECT
    • Cardiology
    • Lymphoma
    • Thyroid
    • Neurology
    • Others
    • PET
    • Oncology
    • Cardiology
    • Neurology
    • Others
    • Therapeutics
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Others

    By Regional Analysis

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Request Sample Report: https://www.marketresearchengine.com/requestsample/nuclear-medicine-market

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Nuclear Medicine Market, By Type

    7 Nuclear Medicine Market, By Application

    8 Nuclear Medicine Market, By Procedural Volume

    9 Global Nuclear Medicine Market, By Region

    10 Global Nuclear Medicine Market, By Region

    11 Competitive Landscape

    12 Company Profiles

    12.1 Introduction

    12.2 Cardinal Health, Inc.

    12.3 Mallinckrodt PLC

    12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)

    12.5 Lantheus Medical Imaging, Inc.

    12.6 Bayer AG

    12.7 Bracco Imaging S.P.A

    12.8 Eczacibasi-Monrol Nuclear Products

    12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)

    12.10 Advanced Accelerator Applications S.A.

    12.11 IBA Molecular

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/nuclear-medicine-radiopharmaceuticals-market-is-expected-to-get-us-4-5-billion-by-2023